First Light Asset Management as of March 31, 2019
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 63 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 7.0 | $54M | 2.2M | 24.38 | |
| Ionis Pharmaceuticals (IONS) | 6.5 | $50M | 611k | 81.17 | |
| Oxford Immunotec Global | 6.1 | $47M | 2.7M | 17.23 | |
| Omnicell (OMCL) | 5.5 | $42M | 522k | 80.84 | |
| Model N (MODN) | 5.0 | $38M | 2.2M | 17.54 | |
| NeoGenomics (NEO) | 4.3 | $33M | 1.6M | 20.46 | |
| Harvard Bioscience (HBIO) | 4.0 | $31M | 7.1M | 4.31 | |
| Heron Therapeutics (HRTX) | 3.5 | $27M | 1.1M | 24.44 | |
| Seaspine Holdings | 3.5 | $27M | 1.8M | 15.08 | |
| Immunomedics | 3.5 | $27M | 1.4M | 19.21 | |
| Nektar Therapeutics (NKTR) | 3.3 | $26M | 763k | 33.60 | |
| AtriCure (ATRC) | 3.2 | $25M | 914k | 26.79 | |
| Halozyme Therapeutics (HALO) | 3.1 | $24M | 1.5M | 16.10 | |
| Intersect Ent | 3.0 | $23M | 720k | 32.15 | |
| Myokardia | 3.0 | $23M | 440k | 51.99 | |
| Aerie Pharmaceuticals | 2.9 | $23M | 474k | 47.50 | |
| Veracyte (VCYT) | 2.5 | $19M | 773k | 25.02 | |
| Tandem Diabetes Care (TNDM) | 2.2 | $17M | 268k | 63.50 | |
| Ligand Pharmaceuticals In (LGND) | 2.1 | $17M | 132k | 125.71 | |
| Xencor (XNCR) | 2.1 | $16M | 511k | 31.06 | |
| Codexis (CDXS) | 1.9 | $15M | 724k | 20.53 | |
| Nuvectra | 1.9 | $15M | 1.3M | 11.01 | |
| Aduro Biotech | 1.9 | $14M | 3.6M | 3.98 | |
| Dynavax Technologies (DVAX) | 1.6 | $13M | 1.7M | 7.31 | |
| Repro-Med Systems (KRMD) | 1.4 | $11M | 6.9M | 1.60 | |
| Mylan Nv | 1.2 | $9.2M | 326k | 28.34 | |
| Takeda Pharmaceutical (TAK) | 1.1 | $8.4M | 413k | 20.37 | |
| Vapotherm | 1.0 | $7.8M | 399k | 19.65 | |
| Alkermes (ALKS) | 1.0 | $7.7M | 211k | 36.49 | |
| Cardiovascular Systems | 0.9 | $7.3M | 188k | 38.66 | |
| Trupanion (TRUP) | 0.8 | $6.3M | 194k | 32.74 | |
| LHC | 0.8 | $6.0M | 54k | 110.85 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $5.8M | 66k | 88.84 | |
| Orthopediatrics Corp. (KIDS) | 0.7 | $5.4M | 123k | 44.23 | |
| Simulations Plus (SLP) | 0.7 | $5.3M | 252k | 21.11 | |
| Bio-techne Corporation (TECH) | 0.7 | $5.3M | 27k | 198.54 | |
| Globus Med Inc cl a (GMED) | 0.7 | $5.1M | 103k | 49.41 | |
| Teva Pharmaceutical Industries (TEVA) | 0.6 | $4.9M | 313k | 15.68 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.6 | $4.9M | 27k | 183.94 | |
| Quidel Corporation | 0.5 | $3.6M | 55k | 65.48 | |
| Bluebird Bio (BLUE) | 0.4 | $2.9M | 19k | 157.34 | |
| HealthStream (HSTM) | 0.3 | $2.5M | 91k | 28.07 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.3 | $2.4M | 21k | 111.82 | |
| Invesco Smallcap Health Care Etf etf | 0.3 | $2.0M | 17k | 115.53 | |
| iShares Dow Jones US Medical Dev. (IHI) | 0.2 | $1.8M | 7.6k | 231.53 | |
| Teligent | 0.2 | $1.8M | 1.5M | 1.16 | |
| Health Care SPDR (XLV) | 0.2 | $1.7M | 18k | 91.77 | |
| LeMaitre Vascular (LMAT) | 0.2 | $1.5M | 49k | 30.99 | |
| Cellectis S A (CLLS) | 0.2 | $1.4M | 75k | 18.34 | |
| Pfizer (PFE) | 0.1 | $360k | 8.5k | 42.51 | |
| Merck & Co (MRK) | 0.1 | $353k | 4.2k | 83.12 | |
| Johnson & Johnson (JNJ) | 0.0 | $302k | 2.2k | 139.75 | |
| Novartis (NVS) | 0.0 | $340k | 3.5k | 96.18 | |
| Sanofi-Aventis SA (SNY) | 0.0 | $294k | 6.7k | 44.21 | |
| Abbvie (ABBV) | 0.0 | $332k | 4.1k | 80.70 | |
| Thermo Fisher Scientific (TMO) | 0.0 | $218k | 797.00 | 273.53 | |
| PerkinElmer (RVTY) | 0.0 | $216k | 2.2k | 96.21 | |
| Amgen (AMGN) | 0.0 | $207k | 1.1k | 189.56 | |
| Hill-Rom Holdings | 0.0 | $225k | 2.1k | 106.08 | |
| Teleflex Incorporated (TFX) | 0.0 | $235k | 777.00 | 302.45 | |
| Dynatronics | 0.0 | $237k | 115k | 2.06 | |
| Anthem (ELV) | 0.0 | $228k | 795.00 | 286.79 | |
| Steris | 0.0 | $211k | 1.6k | 127.96 |
